Management of Hepatitis C Infection with Direct Action Antiviral Drugs (DAA)**
<p>Several new direct action antiviral drugs (DAA) against the HCV virus (HCV) are approved and marketed. The combination of DAA with pegylated interferon and ribavirin (PR) is only recommended to patients with tolerance to interferon (IFN). IFN-free treatments are now considered elective drug...
Saved in:
Main Authors: | , , , |
---|---|
格式: | 圖書 |
出版: |
Archives of Hepatitis Research - Peertechz Publications,
2015-12-30.
|
主題: | |
在線閱讀: | Connect to this object online. |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
因特網
Connect to this object online.3rd Floor Main Library
索引號: |
A1234.567 |
---|---|
復印件 1 | 可用 |